Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitroglycerin | 12 | 2011 | 325 | 2.150 |
Why?
|
Vasodilator Agents | 15 | 2011 | 976 | 1.520 |
Why?
|
Cardiac Pacing, Artificial | 15 | 2009 | 846 | 1.260 |
Why?
|
Sympathetic Nervous System | 8 | 2012 | 514 | 1.250 |
Why?
|
Vasodilation | 11 | 2011 | 944 | 1.130 |
Why?
|
Endothelium, Vascular | 15 | 2012 | 4455 | 1.120 |
Why?
|
Drug Tolerance | 8 | 2011 | 375 | 1.080 |
Why?
|
Angina Pectoris | 9 | 2009 | 977 | 0.790 |
Why?
|
Nitrates | 6 | 2009 | 265 | 0.780 |
Why?
|
Heart Failure | 26 | 2012 | 10856 | 0.750 |
Why?
|
Brachial Artery | 2 | 2011 | 370 | 0.670 |
Why?
|
Inclusion Bodies, Viral | 5 | 2004 | 45 | 0.590 |
Why?
|
Ventricular Function, Left | 13 | 2012 | 3656 | 0.560 |
Why?
|
Hemodynamics | 19 | 2012 | 4197 | 0.560 |
Why?
|
Reoviridae | 5 | 2004 | 161 | 0.550 |
Why?
|
Heart | 27 | 2012 | 4462 | 0.550 |
Why?
|
Isosorbide Dinitrate | 2 | 2007 | 34 | 0.550 |
Why?
|
Nuclear Medicine | 5 | 2003 | 233 | 0.540 |
Why?
|
Norepinephrine | 5 | 2012 | 909 | 0.540 |
Why?
|
Radionuclide Imaging | 45 | 2021 | 2027 | 0.530 |
Why?
|
Dobutamine | 2 | 2008 | 123 | 0.520 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2010 | 476 | 0.480 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2012 | 2059 | 0.470 |
Why?
|
Adrenergic beta-Agonists | 2 | 2008 | 346 | 0.470 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2009 | 851 | 0.440 |
Why?
|
Ischemic Preconditioning, Myocardial | 3 | 2010 | 67 | 0.430 |
Why?
|
Coronary Disease | 19 | 2011 | 6078 | 0.420 |
Why?
|
Coronary Circulation | 10 | 2012 | 1572 | 0.420 |
Why?
|
Pulmonary Embolism | 13 | 2001 | 2370 | 0.400 |
Why?
|
Nitric Oxide Synthase | 3 | 2010 | 916 | 0.380 |
Why?
|
omega-N-Methylarginine | 1 | 2010 | 111 | 0.380 |
Why?
|
Folic Acid | 2 | 2010 | 1300 | 0.370 |
Why?
|
Acetylcholine | 2 | 2010 | 621 | 0.370 |
Why?
|
Free Radicals | 3 | 2009 | 236 | 0.360 |
Why?
|
Radial Artery | 2 | 2010 | 194 | 0.360 |
Why?
|
Piperazines | 5 | 2007 | 2488 | 0.350 |
Why?
|
Metoprolol | 2 | 2011 | 93 | 0.350 |
Why?
|
Propanolamines | 2 | 2011 | 167 | 0.340 |
Why?
|
Myocardial Ischemia | 8 | 2011 | 2145 | 0.330 |
Why?
|
Heptanoic Acids | 1 | 2011 | 343 | 0.330 |
Why?
|
Nitro Compounds | 1 | 2008 | 75 | 0.330 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 11 | 2009 | 1107 | 0.330 |
Why?
|
Double-Blind Method | 18 | 2011 | 12017 | 0.320 |
Why?
|
Vitamin B Complex | 1 | 2010 | 288 | 0.320 |
Why?
|
Carbazoles | 2 | 2011 | 226 | 0.320 |
Why?
|
Sulfones | 3 | 2007 | 437 | 0.320 |
Why?
|
Fluorobenzenes | 1 | 2010 | 184 | 0.310 |
Why?
|
Forearm | 3 | 2010 | 407 | 0.310 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 320 | 0.310 |
Why?
|
Virus Assembly | 4 | 2004 | 144 | 0.310 |
Why?
|
Heart Rate | 13 | 2011 | 4091 | 0.310 |
Why?
|
Organometallic Compounds | 5 | 2021 | 665 | 0.310 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 689 | 0.310 |
Why?
|
Cyclooxygenase 2 | 1 | 2010 | 611 | 0.300 |
Why?
|
Viral Proteins | 6 | 2004 | 1899 | 0.290 |
Why?
|
Nitroprusside | 3 | 2004 | 275 | 0.290 |
Why?
|
Diuretics | 2 | 2007 | 591 | 0.290 |
Why?
|
Regional Blood Flow | 7 | 2010 | 1525 | 0.290 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.280 |
Why?
|
Blood Pressure | 18 | 2012 | 8541 | 0.280 |
Why?
|
Viral Core Proteins | 4 | 2004 | 162 | 0.270 |
Why?
|
Kidney | 3 | 2008 | 7167 | 0.270 |
Why?
|
Phlebography | 2 | 2006 | 333 | 0.270 |
Why?
|
Viral Nonstructural Proteins | 3 | 2004 | 241 | 0.270 |
Why?
|
Nuclear Medicine Department, Hospital | 3 | 2003 | 14 | 0.270 |
Why?
|
Atrioventricular Node | 1 | 2006 | 182 | 0.260 |
Why?
|
Hypertension, Pulmonary | 2 | 2012 | 1527 | 0.260 |
Why?
|
Thallium | 8 | 2003 | 101 | 0.260 |
Why?
|
Cardiac Output | 8 | 2012 | 853 | 0.260 |
Why?
|
Endothelins | 1 | 2005 | 138 | 0.250 |
Why?
|
Sulfonamides | 2 | 2014 | 1932 | 0.250 |
Why?
|
Coronary Angiography | 10 | 2011 | 4567 | 0.240 |
Why?
|
Nitric Oxide Donors | 1 | 2004 | 121 | 0.240 |
Why?
|
Pressoreceptors | 1 | 2004 | 100 | 0.240 |
Why?
|
Pyrroles | 1 | 2011 | 1143 | 0.240 |
Why?
|
Reflex, Abnormal | 1 | 2004 | 85 | 0.240 |
Why?
|
Elasticity Imaging Techniques | 1 | 2009 | 388 | 0.240 |
Why?
|
Pentaerythritol Tetranitrate | 1 | 2003 | 2 | 0.230 |
Why?
|
Vasoconstriction | 4 | 2011 | 596 | 0.230 |
Why?
|
Exercise Tolerance | 2 | 2007 | 770 | 0.230 |
Why?
|
Tissue Plasminogen Activator | 7 | 1997 | 1262 | 0.230 |
Why?
|
Telecommunications | 1 | 2003 | 80 | 0.230 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 2001 | 116 | 0.220 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2009 | 1239 | 0.220 |
Why?
|
Myocardium | 7 | 2010 | 4775 | 0.220 |
Why?
|
Coronary Artery Disease | 7 | 2012 | 6454 | 0.220 |
Why?
|
Cardiotonic Agents | 2 | 2005 | 535 | 0.210 |
Why?
|
Technetium | 13 | 2003 | 334 | 0.210 |
Why?
|
Diastole | 5 | 2003 | 791 | 0.210 |
Why?
|
Thrombolytic Therapy | 7 | 1997 | 2161 | 0.200 |
Why?
|
Baroreflex | 1 | 2002 | 146 | 0.200 |
Why?
|
Meglumine | 4 | 2006 | 149 | 0.190 |
Why?
|
Hyperaldosteronism | 1 | 2004 | 239 | 0.190 |
Why?
|
Humans | 147 | 2021 | 742088 | 0.190 |
Why?
|
Endothelium | 1 | 2003 | 778 | 0.190 |
Why?
|
Computer Communication Networks | 3 | 1998 | 295 | 0.180 |
Why?
|
Internet | 2 | 2003 | 3062 | 0.180 |
Why?
|
Radioisotopes | 9 | 1987 | 499 | 0.180 |
Why?
|
Echocardiography | 12 | 2009 | 5097 | 0.180 |
Why?
|
Heart Ventricles | 10 | 2006 | 3801 | 0.180 |
Why?
|
Middle Aged | 73 | 2021 | 213127 | 0.180 |
Why?
|
Hypertension | 6 | 2010 | 8455 | 0.180 |
Why?
|
Arginine | 2 | 2011 | 944 | 0.180 |
Why?
|
Radiology Information Systems | 2 | 2003 | 523 | 0.180 |
Why?
|
Pyrazoles | 1 | 2010 | 1970 | 0.170 |
Why?
|
Exercise Test | 15 | 2007 | 2075 | 0.170 |
Why?
|
Thallium Radioisotopes | 5 | 2002 | 139 | 0.170 |
Why?
|
Male | 88 | 2021 | 349538 | 0.170 |
Why?
|
Infusions, Intravenous | 5 | 2008 | 2271 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3239 | 0.160 |
Why?
|
Lung | 9 | 2003 | 9826 | 0.160 |
Why?
|
Microtubules | 3 | 2004 | 1090 | 0.160 |
Why?
|
Enzyme Inhibitors | 4 | 2012 | 3800 | 0.150 |
Why?
|
Pyrimidines | 1 | 2010 | 2933 | 0.150 |
Why?
|
Virion | 3 | 2004 | 433 | 0.150 |
Why?
|
Tomography, Emission-Computed | 4 | 2001 | 1144 | 0.150 |
Why?
|
Reference Values | 6 | 2011 | 4982 | 0.150 |
Why?
|
Electrocardiography | 16 | 2007 | 6440 | 0.140 |
Why?
|
Sleep Apnea Syndromes | 4 | 2003 | 941 | 0.140 |
Why?
|
Indium Radioisotopes | 2 | 1993 | 118 | 0.140 |
Why?
|
Capsid Proteins | 3 | 2004 | 479 | 0.140 |
Why?
|
Antioxidants | 1 | 2004 | 1659 | 0.140 |
Why?
|
Telemedicine | 2 | 2003 | 2853 | 0.130 |
Why?
|
Fuzzy Logic | 1 | 1995 | 56 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 594 | 0.130 |
Why?
|
Adult | 53 | 2012 | 213712 | 0.130 |
Why?
|
Urokinase-Type Plasminogen Activator | 4 | 1997 | 337 | 0.130 |
Why?
|
Cross-Over Studies | 3 | 2007 | 2030 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2008 | 10943 | 0.120 |
Why?
|
Indoles | 2 | 2014 | 1834 | 0.120 |
Why?
|
Joints | 2 | 1993 | 326 | 0.120 |
Why?
|
Aged | 51 | 2012 | 162944 | 0.120 |
Why?
|
Purines | 3 | 2007 | 593 | 0.120 |
Why?
|
Orthoreovirus, Mammalian | 2 | 2004 | 40 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 77 | 0.120 |
Why?
|
Physical Exertion | 3 | 2004 | 695 | 0.120 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2009 | 1808 | 0.120 |
Why?
|
Renal Circulation | 2 | 2005 | 333 | 0.120 |
Why?
|
Energy Metabolism | 1 | 2005 | 2896 | 0.120 |
Why?
|
Stroke Volume | 11 | 2011 | 4983 | 0.120 |
Why?
|
Pulmonary Circulation | 4 | 1993 | 739 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 8969 | 0.110 |
Why?
|
Female | 70 | 2021 | 379592 | 0.110 |
Why?
|
Teleradiology | 2 | 2003 | 50 | 0.110 |
Why?
|
Nitric Oxide | 3 | 2012 | 2128 | 0.110 |
Why?
|
Sleep, REM | 1 | 1996 | 594 | 0.110 |
Why?
|
Heart Failure, Systolic | 2 | 2011 | 124 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2003 | 3328 | 0.110 |
Why?
|
Phospholipases A2, Secretory | 1 | 2012 | 31 | 0.100 |
Why?
|
Synovitis | 1 | 1993 | 209 | 0.100 |
Why?
|
Radiopharmaceuticals | 5 | 2003 | 2658 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1914 | 0.100 |
Why?
|
Heart Diseases | 8 | 2010 | 2789 | 0.100 |
Why?
|
Retinal Drusen | 1 | 2012 | 66 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 291 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2010 | 257 | 0.100 |
Why?
|
Fluorescein | 1 | 2012 | 169 | 0.100 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 30 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2008 | 15108 | 0.100 |
Why?
|
Peroneal Nerve | 1 | 2011 | 79 | 0.100 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 994 | 0.100 |
Why?
|
Tetrazoles | 2 | 2007 | 835 | 0.100 |
Why?
|
Injections, Intradermal | 1 | 2010 | 117 | 0.100 |
Why?
|
Drug Administration Routes | 1 | 2011 | 153 | 0.100 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2011 | 50 | 0.090 |
Why?
|
Hemorheology | 1 | 2011 | 145 | 0.090 |
Why?
|
Reactive Oxygen Species | 3 | 2009 | 2077 | 0.090 |
Why?
|
Acetates | 1 | 2012 | 312 | 0.090 |
Why?
|
Administration, Cutaneous | 2 | 2003 | 711 | 0.090 |
Why?
|
Heparin | 3 | 1997 | 1636 | 0.090 |
Why?
|
Teaching | 1 | 1998 | 1174 | 0.090 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2010 | 255 | 0.090 |
Why?
|
Oxidative Stress | 3 | 2011 | 3081 | 0.090 |
Why?
|
Pulmonary Wedge Pressure | 3 | 2007 | 264 | 0.090 |
Why?
|
Vasomotor System | 1 | 2010 | 209 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2010 | 6365 | 0.090 |
Why?
|
Periodicity | 1 | 2011 | 363 | 0.090 |
Why?
|
Premedication | 1 | 2010 | 257 | 0.090 |
Why?
|
Spleen | 1 | 1995 | 2359 | 0.080 |
Why?
|
Sodium Pertechnetate Tc 99m | 2 | 1987 | 57 | 0.080 |
Why?
|
Diltiazem | 2 | 2004 | 133 | 0.080 |
Why?
|
Myocardial Contraction | 7 | 2002 | 1585 | 0.080 |
Why?
|
Renal Plasma Flow | 1 | 2008 | 30 | 0.080 |
Why?
|
Contrast Media | 4 | 2006 | 5295 | 0.080 |
Why?
|
Sleep Apnea, Central | 1 | 2009 | 84 | 0.080 |
Why?
|
Fluconazole | 1 | 2008 | 146 | 0.080 |
Why?
|
Time Factors | 19 | 2011 | 40054 | 0.080 |
Why?
|
Parathyroid Neoplasms | 1 | 2009 | 245 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2001 | 2013 | 0.080 |
Why?
|
Meckel Diverticulum | 1 | 1987 | 34 | 0.080 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 1423 | 0.080 |
Why?
|
Gravitation | 1 | 1987 | 82 | 0.080 |
Why?
|
Adolescent | 11 | 2011 | 85649 | 0.070 |
Why?
|
Amiloride | 1 | 2007 | 121 | 0.070 |
Why?
|
Hydrochlorothiazide | 1 | 2007 | 98 | 0.070 |
Why?
|
Thyroid Neoplasms | 2 | 2014 | 2274 | 0.070 |
Why?
|
Observer Variation | 3 | 2012 | 2593 | 0.070 |
Why?
|
Erythrocytes | 6 | 1987 | 2452 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4249 | 0.070 |
Why?
|
Patients | 1 | 1993 | 892 | 0.070 |
Why?
|
Coronary Vessels | 6 | 2012 | 3099 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4929 | 0.070 |
Why?
|
Blood Circulation | 1 | 2007 | 251 | 0.070 |
Why?
|
Microvessels | 1 | 2011 | 544 | 0.070 |
Why?
|
Microscopy, Fluorescence | 2 | 2004 | 2699 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2011 | 62966 | 0.070 |
Why?
|
Movement | 1 | 1993 | 1470 | 0.070 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2010 | 501 | 0.070 |
Why?
|
Radiography | 6 | 2008 | 7010 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 193 | 0.070 |
Why?
|
Fluorescent Dyes | 2 | 2012 | 1915 | 0.070 |
Why?
|
Autonomic Nervous System | 3 | 2003 | 671 | 0.070 |
Why?
|
Ventricular Function, Right | 2 | 2003 | 592 | 0.070 |
Why?
|
Liver | 3 | 2002 | 7470 | 0.070 |
Why?
|
Administration, Oral | 3 | 2003 | 3913 | 0.060 |
Why?
|
Thymus Hyperplasia | 1 | 2005 | 30 | 0.060 |
Why?
|
Orthoreovirus | 1 | 2004 | 23 | 0.060 |
Why?
|
Myristic Acids | 1 | 2004 | 48 | 0.060 |
Why?
|
Streptokinase | 1 | 1985 | 188 | 0.060 |
Why?
|
Creatinine | 1 | 2010 | 1916 | 0.060 |
Why?
|
Ontario | 3 | 2011 | 381 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2011 | 14720 | 0.060 |
Why?
|
Pyridines | 2 | 2007 | 2818 | 0.060 |
Why?
|
Physical Endurance | 1 | 2007 | 370 | 0.060 |
Why?
|
Acute Disease | 6 | 2007 | 7141 | 0.060 |
Why?
|
Calcium Channel Blockers | 2 | 2007 | 689 | 0.060 |
Why?
|
Glyburide | 1 | 2005 | 113 | 0.060 |
Why?
|
Furosemide | 1 | 2005 | 167 | 0.060 |
Why?
|
Lactates | 1 | 2005 | 432 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2028 | 0.060 |
Why?
|
Macular Degeneration | 1 | 2012 | 980 | 0.060 |
Why?
|
Nucleoside-Triphosphatase | 1 | 2003 | 19 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2038 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1873 | 0.060 |
Why?
|
Jugular Veins | 1 | 2005 | 204 | 0.060 |
Why?
|
Echocardiography, Doppler | 3 | 2006 | 934 | 0.060 |
Why?
|
Renal Veins | 1 | 2004 | 108 | 0.060 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2003 | 72 | 0.060 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 379 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1813 | 0.060 |
Why?
|
Amlodipine | 1 | 2004 | 83 | 0.060 |
Why?
|
Atenolol | 1 | 2004 | 100 | 0.060 |
Why?
|
Body Water | 1 | 1985 | 343 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2007 | 647 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1113 | 0.060 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2005 | 402 | 0.060 |
Why?
|
Coronary Artery Bypass | 2 | 2003 | 2281 | 0.060 |
Why?
|
Plasma Volume | 1 | 2002 | 36 | 0.060 |
Why?
|
Peroxynitrous Acid | 1 | 2002 | 41 | 0.060 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2006 | 269 | 0.060 |
Why?
|
Oxygen | 2 | 2010 | 4169 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2011 | 6483 | 0.050 |
Why?
|
Biotransformation | 1 | 2002 | 168 | 0.050 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2006 | 469 | 0.050 |
Why?
|
Drug Interactions | 1 | 2007 | 1458 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2005 | 578 | 0.050 |
Why?
|
Prodrugs | 1 | 2004 | 268 | 0.050 |
Why?
|
Clonidine | 1 | 2003 | 164 | 0.050 |
Why?
|
Computers | 7 | 1983 | 611 | 0.050 |
Why?
|
Ventricular Pressure | 1 | 2003 | 199 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2006 | 598 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2010 | 1573 | 0.050 |
Why?
|
Parasympathetic Nervous System | 1 | 2002 | 141 | 0.050 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2007 | 546 | 0.050 |
Why?
|
Microscopy, Immunoelectron | 1 | 2002 | 319 | 0.050 |
Why?
|
Potassium Channels | 1 | 2005 | 562 | 0.050 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2006 | 430 | 0.050 |
Why?
|
Cell Line | 4 | 2004 | 15994 | 0.050 |
Why?
|
Gallium Radioisotopes | 2 | 2021 | 178 | 0.050 |
Why?
|
Systems Integration | 1 | 2003 | 440 | 0.050 |
Why?
|
Cricetinae | 2 | 2002 | 2471 | 0.050 |
Why?
|
Superoxides | 1 | 2002 | 386 | 0.050 |
Why?
|
Aged, 80 and over | 14 | 2012 | 57683 | 0.050 |
Why?
|
Specialty Boards | 1 | 2003 | 227 | 0.050 |
Why?
|
Hospital Departments | 3 | 1990 | 137 | 0.050 |
Why?
|
Polysomnography | 4 | 2011 | 1772 | 0.050 |
Why?
|
Placebo Effect | 1 | 2005 | 502 | 0.050 |
Why?
|
Erectile Dysfunction | 1 | 2005 | 459 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2354 | 0.050 |
Why?
|
Vascular Patency | 1 | 2003 | 885 | 0.050 |
Why?
|
Remote Consultation | 1 | 2003 | 238 | 0.050 |
Why?
|
Liver Diseases | 2 | 2002 | 1252 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 2 | 1993 | 3695 | 0.050 |
Why?
|
Saphenous Vein | 1 | 2003 | 531 | 0.050 |
Why?
|
Vascular Resistance | 4 | 2011 | 936 | 0.050 |
Why?
|
Gadolinium DTPA | 2 | 2002 | 836 | 0.050 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2006 | 859 | 0.050 |
Why?
|
Ventricular Function | 3 | 2011 | 416 | 0.050 |
Why?
|
Myocardial Stunning | 1 | 2000 | 68 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2167 | 0.050 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2000 | 134 | 0.050 |
Why?
|
Animals | 17 | 2009 | 168561 | 0.050 |
Why?
|
Chronic Disease | 4 | 2007 | 9144 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2002 | 599 | 0.040 |
Why?
|
Body Mass Index | 5 | 2010 | 12695 | 0.040 |
Why?
|
Selection Bias | 1 | 2002 | 369 | 0.040 |
Why?
|
Device Removal | 1 | 2005 | 652 | 0.040 |
Why?
|
Transfection | 3 | 2003 | 5892 | 0.040 |
Why?
|
Posture | 2 | 2003 | 958 | 0.040 |
Why?
|
Muscles | 1 | 1985 | 1617 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2005 | 1869 | 0.040 |
Why?
|
Sex Factors | 2 | 2010 | 10392 | 0.040 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 66 | 0.040 |
Why?
|
Ubiquitin | 1 | 2004 | 849 | 0.040 |
Why?
|
Data Collection | 1 | 1989 | 3339 | 0.040 |
Why?
|
Software | 4 | 2002 | 4434 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2003 | 701 | 0.040 |
Why?
|
Protein Conformation | 2 | 2004 | 4013 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2000 | 175 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2004 | 2187 | 0.040 |
Why?
|
Reference Books | 1 | 1998 | 2 | 0.040 |
Why?
|
Thromboembolism | 1 | 2005 | 983 | 0.040 |
Why?
|
Myocardial Infarction | 6 | 2009 | 11690 | 0.040 |
Why?
|
CD-ROM | 1 | 1998 | 24 | 0.040 |
Why?
|
Ultrasonography | 3 | 2008 | 5978 | 0.040 |
Why?
|
Veins | 1 | 2003 | 769 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2001 | 1003 | 0.040 |
Why?
|
Cause of Death | 2 | 2007 | 3571 | 0.040 |
Why?
|
Retrospective Studies | 9 | 2021 | 77098 | 0.040 |
Why?
|
Recombinant Proteins | 4 | 2003 | 6608 | 0.040 |
Why?
|
Hypotension | 2 | 1995 | 880 | 0.040 |
Why?
|
Microcomputers | 1 | 1998 | 147 | 0.040 |
Why?
|
Arteries | 1 | 2003 | 1118 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2004 | 848 | 0.040 |
Why?
|
Gadolinium | 1 | 2002 | 951 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20086 | 0.040 |
Why?
|
Blood Vessels | 1 | 2002 | 1124 | 0.040 |
Why?
|
Ventricular Remodeling | 1 | 2004 | 1224 | 0.040 |
Why?
|
Subtraction Technique | 1 | 1980 | 525 | 0.040 |
Why?
|
Prospective Studies | 11 | 2012 | 53187 | 0.040 |
Why?
|
Fibrinolytic Agents | 3 | 1997 | 2156 | 0.040 |
Why?
|
Prognosis | 6 | 2009 | 29010 | 0.030 |
Why?
|
Atrial Fibrillation | 2 | 2005 | 5019 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 477 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2005 | 8925 | 0.030 |
Why?
|
Kidney Cortex | 1 | 1976 | 186 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4933 | 0.030 |
Why?
|
Pulmonary Artery | 3 | 2000 | 1911 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2005 | 1440 | 0.030 |
Why?
|
Young Adult | 3 | 2011 | 56350 | 0.030 |
Why?
|
Educational Technology | 1 | 1995 | 60 | 0.030 |
Why?
|
ROC Curve | 3 | 2011 | 3528 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2002 | 964 | 0.030 |
Why?
|
Systole | 3 | 2006 | 956 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3563 | 0.030 |
Why?
|
RNA, Viral | 1 | 2003 | 2899 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2739 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2004 | 1899 | 0.030 |
Why?
|
Iridium | 2 | 1986 | 92 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 35342 | 0.030 |
Why?
|
Regression Analysis | 2 | 2003 | 6452 | 0.030 |
Why?
|
Genotype | 2 | 2014 | 12946 | 0.030 |
Why?
|
Research Design | 2 | 2007 | 5979 | 0.030 |
Why?
|
Severity of Illness Index | 5 | 2007 | 15530 | 0.030 |
Why?
|
Tachycardia | 5 | 1991 | 620 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2002 | 1263 | 0.030 |
Why?
|
Acetanilides | 2 | 2004 | 168 | 0.030 |
Why?
|
Valine | 1 | 2014 | 413 | 0.030 |
Why?
|
Probability | 2 | 2006 | 2502 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1992 | 213 | 0.030 |
Why?
|
Keto Acids | 1 | 2012 | 34 | 0.030 |
Why?
|
Peptides | 1 | 2004 | 4392 | 0.030 |
Why?
|
Syncope | 1 | 1995 | 429 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 1996 | 632 | 0.030 |
Why?
|
Ventriculography, First-Pass | 1 | 1991 | 20 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5724 | 0.030 |
Why?
|
Mathematics | 2 | 1983 | 727 | 0.030 |
Why?
|
Dogs | 5 | 1991 | 3910 | 0.030 |
Why?
|
Patient Selection | 2 | 2001 | 4214 | 0.030 |
Why?
|
Constriction | 1 | 2011 | 181 | 0.030 |
Why?
|
Calcinosis | 1 | 2000 | 1497 | 0.020 |
Why?
|
Mutation | 2 | 2014 | 29717 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 1992 | 192 | 0.020 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 1994 | 485 | 0.020 |
Why?
|
Sex Distribution | 2 | 2007 | 2295 | 0.020 |
Why?
|
Rheology | 1 | 2012 | 345 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 1990 | 23 | 0.020 |
Why?
|
Mice | 5 | 2004 | 81045 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4801 | 0.020 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 12958 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 7901 | 0.020 |
Why?
|
Indium | 1 | 1990 | 46 | 0.020 |
Why?
|
Age Distribution | 2 | 2007 | 2900 | 0.020 |
Why?
|
Hyperhomocysteinemia | 1 | 2011 | 124 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1884 | 0.020 |
Why?
|
Supination | 1 | 1990 | 68 | 0.020 |
Why?
|
Transposition of Great Vessels | 1 | 1994 | 585 | 0.020 |
Why?
|
Eating | 2 | 1995 | 1535 | 0.020 |
Why?
|
Case-Control Studies | 5 | 2007 | 21719 | 0.020 |
Why?
|
Bone and Bones | 1 | 2000 | 2575 | 0.020 |
Why?
|
Cardiac Volume | 1 | 1990 | 210 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18112 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2002 | 3527 | 0.020 |
Why?
|
Cerebral Hemorrhage | 2 | 1997 | 2643 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1167 | 0.020 |
Why?
|
Hemorrhage | 2 | 1997 | 3461 | 0.020 |
Why?
|
Models, Biological | 2 | 2002 | 9581 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2002 | 176 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2003 | 13029 | 0.020 |
Why?
|
Phenotype | 2 | 2004 | 16331 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2009 | 339 | 0.020 |
Why?
|
Survival Analysis | 3 | 2007 | 10248 | 0.020 |
Why?
|
Prevalence | 3 | 2011 | 15194 | 0.020 |
Why?
|
Clinical Competence | 1 | 2003 | 4681 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1992 | 663 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2012 | 936 | 0.020 |
Why?
|
Plasminogen Activators | 2 | 1997 | 209 | 0.020 |
Why?
|
Dyspnea | 2 | 2007 | 1298 | 0.020 |
Why?
|
Computer Systems | 1 | 1989 | 483 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2203 | 0.020 |
Why?
|
Platelet Activation | 1 | 2011 | 671 | 0.020 |
Why?
|
Hypotension, Orthostatic | 1 | 1990 | 255 | 0.020 |
Why?
|
Wisconsin | 1 | 2006 | 124 | 0.020 |
Why?
|
Nifedipine | 1 | 2007 | 226 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1653 | 0.020 |
Why?
|
Pulse | 1 | 1986 | 229 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9639 | 0.020 |
Why?
|
DNA, Viral | 2 | 2003 | 2224 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3557 | 0.020 |
Why?
|
Papillary Muscles | 1 | 1986 | 200 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6259 | 0.020 |
Why?
|
Spironolactone | 1 | 2009 | 382 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5948 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2009 | 9941 | 0.020 |
Why?
|
Virus Replication | 2 | 2004 | 2531 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 1983 | 1130 | 0.020 |
Why?
|
Antipyrine | 1 | 1985 | 40 | 0.020 |
Why?
|
Phosphocreatine | 1 | 1985 | 269 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 1985 | 193 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2004 | 37 | 0.020 |
Why?
|
Nocodazole | 1 | 2004 | 97 | 0.020 |
Why?
|
Kidney Diseases | 1 | 1976 | 2145 | 0.020 |
Why?
|
Lepidoptera | 1 | 2004 | 23 | 0.020 |
Why?
|
Spodoptera | 1 | 2004 | 153 | 0.020 |
Why?
|
Baculoviridae | 1 | 2004 | 118 | 0.020 |
Why?
|
Computer Simulation | 1 | 1998 | 6191 | 0.020 |
Why?
|
Syndrome | 1 | 2011 | 3248 | 0.020 |
Why?
|
Phosphines | 1 | 2003 | 18 | 0.020 |
Why?
|
Telephone | 2 | 1989 | 617 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1517 | 0.020 |
Why?
|
Follow-Up Studies | 6 | 2005 | 39004 | 0.020 |
Why?
|
Radionuclide Ventriculography | 2 | 1994 | 41 | 0.020 |
Why?
|
Incidence | 3 | 2007 | 20928 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2009 | 1342 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15056 | 0.010 |
Why?
|
Captopril | 1 | 2004 | 272 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1538 | 0.010 |
Why?
|
Child, Preschool | 4 | 2006 | 40955 | 0.010 |
Why?
|
Electrophysiology | 1 | 2006 | 1309 | 0.010 |
Why?
|
Aorta | 1 | 1991 | 2057 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2005 | 279 | 0.010 |
Why?
|
Genes, Viral | 1 | 2004 | 718 | 0.010 |
Why?
|
Angiocardiography | 4 | 1979 | 162 | 0.010 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2003 | 110 | 0.010 |
Why?
|
Aging | 2 | 1993 | 8626 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 2002 | 8829 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
Nucleotides | 1 | 1985 | 463 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2003 | 159 | 0.010 |
Why?
|
Jejunal Diseases | 1 | 1983 | 50 | 0.010 |
Why?
|
Visual Acuity | 1 | 2012 | 2520 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 579 | 0.010 |
Why?
|
Age Factors | 3 | 2009 | 18355 | 0.010 |
Why?
|
Licensure | 1 | 2003 | 124 | 0.010 |
Why?
|
Hydrolysis | 1 | 2003 | 682 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2004 | 590 | 0.010 |
Why?
|
Heart Septum | 1 | 1983 | 313 | 0.010 |
Why?
|
Comorbidity | 2 | 2007 | 10372 | 0.010 |
Why?
|
Angiography | 4 | 1997 | 1636 | 0.010 |
Why?
|
Neoplasms | 2 | 2003 | 21596 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1986 | 643 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12797 | 0.010 |
Why?
|
Inflammation | 2 | 2012 | 10578 | 0.010 |
Why?
|
Radiology | 1 | 1995 | 2090 | 0.010 |
Why?
|
Safety | 1 | 2006 | 1185 | 0.010 |
Why?
|
Homeostasis | 2 | 2009 | 3335 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1985 | 1030 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2885 | 0.010 |
Why?
|
Protein Folding | 1 | 2004 | 843 | 0.010 |
Why?
|
Jejunum | 1 | 1983 | 480 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 380 | 0.010 |
Why?
|
Tissue and Organ Harvesting | 1 | 2003 | 355 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2005 | 824 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2003 | 548 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2795 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2003 | 985 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 686 | 0.010 |
Why?
|
Thymus Gland | 1 | 2005 | 1264 | 0.010 |
Why?
|
Heroin | 1 | 2000 | 117 | 0.010 |
Why?
|
Professional Competence | 1 | 2003 | 448 | 0.010 |
Why?
|
Respiration | 1 | 1986 | 1645 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1792 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1976 | 4566 | 0.010 |
Why?
|
Organ Size | 1 | 1985 | 2253 | 0.010 |
Why?
|
Heroin Dependence | 1 | 2000 | 175 | 0.010 |
Why?
|
CHO Cells | 1 | 2002 | 1407 | 0.010 |
Why?
|
Methods | 2 | 1987 | 1128 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 1983 | 412 | 0.010 |
Why?
|
Signal Transduction | 1 | 2002 | 23387 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1976 | 4229 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2003 | 2505 | 0.010 |
Why?
|
Rhabdomyolysis | 1 | 2000 | 150 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2003 | 2024 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1310 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1589 | 0.010 |
Why?
|
Sleep | 2 | 2006 | 4604 | 0.010 |
Why?
|
Pyridones | 1 | 1983 | 712 | 0.010 |
Why?
|
Suture Techniques | 1 | 2003 | 797 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10472 | 0.010 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2003 | 721 | 0.010 |
Why?
|
Child | 4 | 2006 | 77478 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1986 | 1402 | 0.010 |
Why?
|
Narcotics | 1 | 2000 | 343 | 0.010 |
Why?
|
False Positive Reactions | 2 | 1994 | 981 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2006 | 1541 | 0.010 |
Why?
|
Temperature | 1 | 2004 | 2207 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2002 | 1526 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16665 | 0.010 |
Why?
|
Melena | 1 | 1997 | 34 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 659 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2002 | 737 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2002 | 1086 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 1997 | 206 | 0.010 |
Why?
|
Rest | 1 | 2002 | 900 | 0.010 |
Why?
|
Thorax | 2 | 1994 | 547 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1986 | 1415 | 0.010 |
Why?
|
Hemiplegia | 1 | 1997 | 135 | 0.010 |
Why?
|
Risk Factors | 4 | 2011 | 72145 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2372 | 0.010 |
Why?
|
Hemangioma | 1 | 1981 | 737 | 0.010 |
Why?
|
Cineangiography | 2 | 1987 | 124 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9185 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13403 | 0.010 |
Why?
|
Hematuria | 1 | 1997 | 235 | 0.010 |
Why?
|
Hematocrit | 1 | 1997 | 636 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2906 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1995 | 110 | 0.010 |
Why?
|
Information Systems | 1 | 1997 | 410 | 0.010 |
Why?
|
Risk Assessment | 2 | 2007 | 23320 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6115 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2043 | 0.010 |
Why?
|
Consensus | 1 | 2003 | 2935 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2000 | 1093 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3770 | 0.010 |
Why?
|
Swine | 1 | 2003 | 5934 | 0.010 |
Why?
|
Graft Survival | 1 | 2003 | 3733 | 0.010 |
Why?
|
Heart Function Tests | 1 | 1973 | 330 | 0.010 |
Why?
|
Serum Albumin | 2 | 1973 | 674 | 0.010 |
Why?
|
Blood Volume Determination | 1 | 1972 | 43 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12344 | 0.010 |
Why?
|
Computer-Assisted Instruction | 1 | 1995 | 365 | 0.010 |
Why?
|
Recurrence | 2 | 1997 | 8333 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1997 | 1661 | 0.010 |
Why?
|
Isoproterenol | 1 | 1972 | 399 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2003 | 3465 | 0.010 |
Why?
|
Drinking | 1 | 1993 | 197 | 0.010 |
Why?
|
Catheterization | 1 | 1997 | 1468 | 0.010 |
Why?
|
Consciousness | 1 | 1997 | 571 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13814 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1997 | 2970 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1994 | 585 | 0.010 |
Why?
|
Propranolol | 1 | 1972 | 502 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1996 | 1459 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4393 | 0.010 |
Why?
|
Visual Fields | 1 | 1997 | 1049 | 0.010 |
Why?
|
Vision Disorders | 1 | 1997 | 1057 | 0.010 |
Why?
|
Random Allocation | 1 | 1994 | 2425 | 0.010 |
Why?
|
Patient Admission | 1 | 1997 | 1380 | 0.010 |
Why?
|
Infant | 2 | 2006 | 35070 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1976 | 1499 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29087 | 0.010 |
Why?
|
Biopsy | 1 | 2000 | 6756 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2004 | 19223 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1982 | 1676 | 0.010 |
Why?
|
Publishing | 1 | 1995 | 833 | 0.000 |
Why?
|
Cohort Studies | 1 | 2011 | 40450 | 0.000 |
Why?
|
Biometry | 1 | 1991 | 558 | 0.000 |
Why?
|
Heart Atria | 2 | 1984 | 1348 | 0.000 |
Why?
|
Hospital Information Systems | 1 | 1990 | 395 | 0.000 |
Why?
|
Asthma | 1 | 1986 | 5955 | 0.000 |
Why?
|
Acute Kidney Injury | 1 | 2000 | 1967 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3510 | 0.000 |
Why?
|
Synovial Membrane | 1 | 1990 | 506 | 0.000 |
Why?
|
Drug Combinations | 1 | 1992 | 1961 | 0.000 |
Why?
|
Glioblastoma | 1 | 2002 | 3456 | 0.000 |
Why?
|
Hemothorax | 1 | 1986 | 59 | 0.000 |
Why?
|
Radionuclide Generators | 1 | 1986 | 12 | 0.000 |
Why?
|
Fibrin | 1 | 1988 | 506 | 0.000 |
Why?
|
Nucleosides | 1 | 1985 | 138 | 0.000 |
Why?
|
Fibrinogen | 1 | 1988 | 894 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2003 | 19862 | 0.000 |
Why?
|
Cardiomegaly | 1 | 1987 | 619 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1972 | 1737 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15244 | 0.000 |
Why?
|
Vital Capacity | 1 | 1986 | 922 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1997 | 5310 | 0.000 |
Why?
|
Cost-Benefit Analysis | 2 | 1989 | 5385 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1997 | 12242 | 0.000 |
Why?
|
Milrinone | 1 | 1983 | 84 | 0.000 |
Why?
|
Phenylephrine | 1 | 1984 | 301 | 0.000 |
Why?
|
Pressure | 1 | 1986 | 1203 | 0.000 |
Why?
|
Technology, Radiologic | 1 | 1983 | 163 | 0.000 |
Why?
|
Splenic Rupture | 1 | 1982 | 26 | 0.000 |
Why?
|
Survival Rate | 1 | 1997 | 12773 | 0.000 |
Why?
|
Pubic Bone | 1 | 1982 | 29 | 0.000 |
Why?
|
Electricity | 1 | 1983 | 182 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1983 | 637 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 24913 | 0.000 |
Why?
|
Osteoarthritis | 1 | 1990 | 1034 | 0.000 |
Why?
|
Anticoagulants | 1 | 1997 | 4595 | 0.000 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1981 | 66 | 0.000 |
Why?
|
Cranial Fossa, Posterior | 1 | 1982 | 139 | 0.000 |
Why?
|
Accidental Falls | 1 | 1990 | 1057 | 0.000 |
Why?
|
Data Display | 1 | 1981 | 182 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1983 | 1420 | 0.000 |
Why?
|
Diverticulitis, Colonic | 1 | 1982 | 127 | 0.000 |
Why?
|
Gallbladder | 1 | 1982 | 301 | 0.000 |
Why?
|
Sulfur | 1 | 1981 | 166 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1985 | 2552 | 0.000 |
Why?
|
Sacrum | 1 | 1982 | 289 | 0.000 |
Why?
|
Esophagus | 1 | 1986 | 1017 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1986 | 1080 | 0.000 |
Why?
|
Photography | 1 | 1983 | 521 | 0.000 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1983 | 475 | 0.000 |
Why?
|
Stress, Mechanical | 1 | 1984 | 1684 | 0.000 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1983 | 719 | 0.000 |
Why?
|
Electroencephalography | 1 | 1992 | 6142 | 0.000 |
Why?
|
Perfusion | 1 | 1981 | 1359 | 0.000 |
Why?
|
Nitrogen Radioisotopes | 1 | 1976 | 44 | 0.000 |
Why?
|
Oxygen Radioisotopes | 1 | 1976 | 76 | 0.000 |
Why?
|
Vestibulocochlear Nerve | 1 | 1976 | 116 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 13853 | 0.000 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 1976 | 123 | 0.000 |
Why?
|
Ammonia | 1 | 1976 | 239 | 0.000 |
Why?
|
Internship and Residency | 1 | 1995 | 5774 | 0.000 |
Why?
|
United States | 1 | 2003 | 69693 | 0.000 |
Why?
|
Spine | 1 | 1982 | 1143 | 0.000 |
Why?
|
Cineradiography | 1 | 1973 | 24 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 25575 | 0.000 |
Why?
|
Embolization, Therapeutic | 1 | 1982 | 1392 | 0.000 |
Why?
|
Astrocytoma | 1 | 1976 | 789 | 0.000 |
Why?
|
Neurilemmoma | 1 | 1976 | 547 | 0.000 |
Why?
|
Pain | 1 | 1984 | 4961 | 0.000 |
Why?
|
Meningioma | 1 | 1976 | 1209 | 0.000 |
Why?
|
Mitral Valve | 1 | 1973 | 1484 | 0.000 |
Why?
|
Aortic Valve | 1 | 1973 | 1911 | 0.000 |
Why?
|
Glioma | 1 | 1976 | 3388 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1976 | 6347 | 0.000 |
Why?
|